Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Todd Neale

October 09, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Conference News TCT 2019

#CardioQuiz Engages Cardiology Learners Through Twitter Polls, Discussion

Yael L. Maxwell

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Presentation TCT 2019

Direct Sodium Removal With an Ambulatory Peritoneal Dialysis System: Sequana

Presenter: Jeffrey Testani

September 28, 2019

Presentation TCT 2019

PROMISE: Cost-Effectiveness Analysis of Non-Invasive FFRCT, CTA Alone, and Functional Testing for Stable Chest Pain Evaluation

Presenter: Hoffmann Udo

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Presenter: Mark Reisman

September 27, 2019

Presentation TCT 2019

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Presenter: Bruce Samuels

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

Presenter: Francesco Franchi

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Conference News TCT 2019

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Yael L. Maxwell

September 25, 2019

Advertisement

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

#CardioQuiz Engages Cardiology Learners Through Twitter Polls, Discussion

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Direct Sodium Removal With an Ambulatory Peritoneal Dialysis System: Sequana

PROMISE: Cost-Effectiveness Analysis of Non-Invasive FFRCT, CTA Alone, and Functional Testing for Stable Chest Pain Evaluation

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content